News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

My Biz

Submit content

My Account

Advertise with us

News South Africa

FDA mandates increased warnings for epilepsy drugs, stops short of issuing black box

The U.S. FDA has increased label warnings for epilepsy drugs, noting the increased risk of suicidal thoughts and behaviours, after a panel review earlier this year.

The U.S. FDA has issued new labelling guidelines for drugs used in the treatment of epilepsy. The agency has announced that the directive is relevant for all anti-epileptic drugs, including those for treating psychiatric disorders, migraine headaches, and other conditions.

Read the full article here

Let's do Biz